Established and emerging strategies for drug delivery across the blood-brain barrier in brain cancer

74Citations
Citations of this article
123Readers
Mendeley users who have this article in their library.

Abstract

Brain tumors are characterized by very high mortality and, despite the continuous research on new pharmacological interventions, little therapeutic progress has been made. One of the main obstacles to improve current treatments is represented by the impermeability of the blood vessels residing within nervous tissue as well as of the new vascular net generating from the tumor, commonly referred to as blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB), respectively. In this review, we focused on established and emerging strategies to overcome the blood-brain barrier to increase drug delivery for brain cancer. To date, there are three broad strategies being investigated to cross the brain vascular wall and they are conceived to breach, bypass, and negotiate the access to the nervous tissue. In this paper, we summarized these approaches highlighting their working mechanism and their potential impact on the quality of life of the patients as well as their current status of development.

Cite

CITATION STYLE

APA

Parodi, A., Rudzińska, M., Deviatkin, A. A., Soond, S. M., Baldin, A. V., & Zamyatnin, A. A. (2019, May 1). Established and emerging strategies for drug delivery across the blood-brain barrier in brain cancer. Pharmaceutics. MDPI AG. https://doi.org/10.3390/pharmaceutics11050245

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free